313 related articles for article (PubMed ID: 33173433)
1. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
Wu CC; Ekanem TI; Phan NN; Loan DTT; Hou SY; Lee KH; Wang CY
Int J Med Sci; 2020; 17(18):3112-3124. PubMed ID: 33173433
[TBL] [Abstract][Full Text] [Related]
2. Distinct expression pattern and prognostic values of pituitary tumor transforming gene family genes in non-small cell lung cancer.
Yang S; Wang X; Liu J; Ding B; Shi K; Chen J; Lou W
Oncol Lett; 2019 Nov; 18(5):4481-4494. PubMed ID: 31611957
[TBL] [Abstract][Full Text] [Related]
3. Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer.
Kao TJ; Wu CC; Phan NN; Liu YH; Ta HDK; Anuraga G; Wu YF; Lee KH; Chuang JY; Wang CY
Aging (Albany NY); 2021 Jul; 13(14):17970. PubMed ID: 34329194
[TBL] [Abstract][Full Text] [Related]
4. Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.
Song X; Zhang T; Wang X; Liao X; Han C; Yang C; Su K; Cao W; Gong Y; Chen Z; Han Q; Li J
Med Sci Monit; 2018 Dec; 24():9442-9464. PubMed ID: 30593585
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression.
Meng C; Zou Y; Hong W; Bao C; Jia X
Mol Med; 2020 Apr; 26(1):33. PubMed ID: 32272902
[TBL] [Abstract][Full Text] [Related]
6. Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma.
Gui Y; Liu X; Wang C; Yang P
World J Surg Oncol; 2021 Apr; 19(1):111. PubMed ID: 33845847
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck.
Solbach C; Roller M; Eckerdt F; Peters S; Knecht R
BMC Cancer; 2006 Oct; 6():242. PubMed ID: 17029632
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of pituitary tumor transforming gene in tumorigenesis.
Tfelt-Hansen J; Kanuparthi D; Chattopadhyay N
Clin Med Res; 2006 Jun; 4(2):130-7. PubMed ID: 16809406
[TBL] [Abstract][Full Text] [Related]
9. The pituitary tumor transforming gene in thyroid cancer.
Lewy GD; Sharma N; Seed RI; Smith VE; Boelaert K; McCabe CJ
J Endocrinol Invest; 2012 Apr; 35(4):425-33. PubMed ID: 22522436
[TBL] [Abstract][Full Text] [Related]
10. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
[TBL] [Abstract][Full Text] [Related]
12. Effect of PTTG on endogenous gene expression in HEK 293 cells.
Panguluri SK; Kakar SS
BMC Genomics; 2009 Dec; 10():577. PubMed ID: 19958546
[TBL] [Abstract][Full Text] [Related]
13. High FAS expression correlates with a better prognosis and efficacy of taxanes and target regents in breast cancer.
Zhang Y; Shao X; Gao C; Xu D; Wu J; Zhu X; Chen Z
Cancer Biomark; 2021; 32(2):207-219. PubMed ID: 34092611
[TBL] [Abstract][Full Text] [Related]
14. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
15. Expression of pituitary tumor-transforming gene in endometrial cancer as a prognostic marker.
Kim JW; Song JY; Lee JM; Lee JK; Lee NW; Yeom BW; Lee KW
Int J Gynecol Cancer; 2008; 18(6):1352-9. PubMed ID: 18217976
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumor-transforming gene and its binding factor in endocrine cancer.
Smith VE; Franklyn JA; McCabe CJ
Expert Rev Mol Med; 2010 Dec; 12():e38. PubMed ID: 21129230
[TBL] [Abstract][Full Text] [Related]
17. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
McCabe CJ; Khaira JS; Boelaert K; Heaney AP; Tannahill LA; Hussain S; Mitchell R; Olliff J; Sheppard MC; Franklyn JA; Gittoes NJ
Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Yang Y; Chen L; Zheng D; Ma J
Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
Boelaert K; McCabe CJ; Tannahill LA; Gittoes NJ; Holder RL; Watkinson JC; Bradwell AR; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
[TBL] [Abstract][Full Text] [Related]
20. Tumorigenic potential of pituitary tumor transforming gene (PTTG) in vivo investigated using a transgenic mouse model, and effects of cross breeding with p53 (+/-) transgenic mice.
Fong MY; Farghaly H; Kakar SS
BMC Cancer; 2012 Nov; 12():532. PubMed ID: 23164239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
